by Sydney Braun | May 14, 2025 | Uncategorized
Cell and gene therapy developers continually encounter significant hurdles during the fill & finish phase—challenges best illustrated by manual workflows that are prone to variability, risk of contamination, and limited scalability. This whitepaper, authored by...
